Graham Capital Management, L.P. Cabaletta Bio, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 17,966 shares of CABA stock, worth $71,504. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,966
Previous 31,174
42.37%
Holding current value
$71,504
Previous $531,000
74.76%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding CABA
# of Institutions
145Shares Held
50.1MCall Options Held
19.9KPut Options Held
41.5K-
Jennison Associates LLC5.55MShares$22.1 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.76MShares$18.9 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$15.4 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.04MShares$12.1 Million0.04% of portfolio
-
Alkeon Capital Management LLC New York, NY2.62MShares$10.4 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $115M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...